This trial is evaluating whether KF-STRIDE will improve 3 primary outcomes in patients with Autism Spectrum Disorder. Measurement will happen over the course of Week 8.
This trial requires 30 total participants across 2 different treatment groups
This trial involves 2 different treatments. KF-STRIDE is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Interest in trials of medications and dietary supplements is fairly common. The best way to recruit for clinical trials on ASD is to offer participants, and their parents, a choice of when and how to enter the clinical trial registry when considering participation in a clinical trial.
Around 80,000 boys and girls in the United States will develop ASD in their lifetime, but not all of them will be diagnosed. People with ASD may be overlooked in the public health system and research. We suggest more effective and efficient ways to diagnose ASD while the diagnosis rate remains below 40 per 10,000 population.
Atypical presentation and other comorbidities may make diagnosis a challenge in early life. The strongest risk factor to date is the combination of measles during infancy and maternal immunization, or high exposure to rubella. Maternal immune hyporesponsiveness to rubella during pregnancy appears to protect against autism, and may also protect from schizophrenia. Possible epigenetic mechanisms include epigenetic changes, chromosomal abnormalities, and a maternal genome with changes in gene expression pattern.
Prenatal diagnosis is a risk factor for autism; however, diagnosis of ASD may be delayed due to lack of family awareness and failure to recognize the signs of ASD. There is an alarming prevalence of ASD on the autism spectrum.
Autism spectrum, in the DSM-5, is categorized into three 'autism subtypes'. These include autistic disorder, as well as two other ASD'specifications' and three other ASD 'conditions'. This article examines the 'autistic spectrum', its variants, as well as the ASD spectrum conditions.\n
Individuals with autism spectrum disorder are frequently treated using medications including stimulants, antidepressants, and behavioural therapies that attempt to control behavioural problems. Additional research is needed into treatments that focus more directly on removing behavioral problems in individuals with ASD.
The question of whether or not autism spectrum disorder is curable raises a number of important policy issues. If the question of cure for ASD cannot be answered for the time being, we suggest a commitment, a focus on prevention, and an improved understanding of the biological and behavioral mechanisms underlying autism.
A kf stride is a change in the length of a footplate on a footgear to enable comfortable use of a shoe. It is a common footwear-related intervention that allows most people with foot anatomy and foot health issues to use and tolerate shoes.
Results indicate that the primary causes of ASD are epigenetic abnormalities that occur during germ cell formation, and genetic abnormalities that occur in the mother. Results from a recent paper suggest that ASD may have a polygenic basis, caused by complex genetic and non-genetic factors, rather than a single predominant defect in the causation of ASD.
Our case illustrates that the treatment plan must be customized to the individual needs of the child and family in order for the child to improve dramatically.
The overall quality of life of patients with autism spectrum disorder is not excellent. However, most patients are satisfied with treatment received in adulthood. Moreover, many of their caregivers would like better ways to recognize and treat autism spectrum disorder in infants earlier because of its serious impact on the quality of life of most young patients and their caregivers.
Although the results of earlier trials and reviews were promising, further research and the development of kf-stride have not produced more consistent results. It is necessary for the development of studies on kf-stride to use a protocol that evaluates and collects data on motor performance.